CryoLife Litigation and Recent Developments.

MINNEAPOLIS, January 15, 2010 -

On January 11, 2010, Medafor moved to dismiss CryoLife's Second Amended Complaint.  The brief in support of its motion is here.

CryoLife filed its Second Amended Complaint on December 28, 2009, after the District Court granted in part Medafor's motion to dismiss CryoLife's First Amended Complaint against Medafor.  The Court directed CryoLife to recast its complaint as directed by the Court.  The Court's order is here.

On December 18, 2009, CryoLife filed a motion for partial reconsideration of the December 9 order, asking the Court to reconsider its decision to dismiss CryoLife's fraud claims against CryoLife.  Medafor filed a response to CryoLife's motion on January 4, 2010.  CryoLife replied on January 6, 2010.

 BACK.

2004-2009

2000-2003

HOME | ABOUT MEDAFOR | PRODUCTS | TECHNOLOGY | RESEARCH | MEDIA CENTER | CONTACT US

Medafor, Inc., was founded in 1999 to develop and market applications for its patented MPH® (Microporous Polysaccharide Hemospheres Technology). Statements presented on this page have not been evaluated by the U.S. FDA. See respective Instructions for Use for product applications and indications. Site content and images Copyright 2008 Medafor, Inc. All Rights Reserved. No part of this site may be copied, republished, excerpted or transferred to other media without the express written consent of Medafor, Inc. Arista™AH, MPH®, Medafor®, MPatcH®, FlexiTip™ are trademarks of Medafor, Inc. Other trademarks mentioned are the property of their respective companies. For information, contact Medafor at 1-763-571-6300.